期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 7, 期 6, 页码 595-600出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00044
关键词
Sorafenib; CDK8; inhibitor; DMG-out
Using Sorafenib as a starting point, a series of potent and selective inhibitors of CDK8 was developed. When cocrystallized with CDK8 and cyclin C, these compounds exhibit a Type-II (DMG-out) binding mode.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据